GranitesharesHealthBIOY · Nasdaq

GraniteShares YieldBOOST Biotech ETF (BIOY)

Compare categoryCompare Option Income ETFs Compare with others

Price: $18.86; —12 Nov 2026
Assets: $1.5M; Total net assets
Expense ratio: 1.07%; Category 0.88%
Yield: —; Trailing distributions

1Y return: —; Category 23.8%
3Y CAGR: —; Category 20.2%
5Y CAGR: —; Category 3.9%

$18.86—12 Nov 2026

Fund

Assets: $1.5M
Expense: 1.07%
Categ. exp: 0.88%
Yield: —

ReturnFundCateg.

1Y—23.8%

3Y—20.2%

5Y—3.9%

Launch2.8%—

Loading NAV history…

GraniteShares YieldBOOST Biotech ETF

Calendar-year returns

Fund only: no comparison series covers this fund's history.

Risk statistics

Five years of daily closes. Risk-free rate 4% a year.

Standard deviation: —
Maximum drawdown: —
Sharpe ratio: —
Sortino ratio: —
Beta: —
Alpha: —
R²: —
Information ratio: —
Upside capture: —
Downside capture: —
Tracking error: —

Trailing returns compared with benchmark
Period	1M	3M	6M	YTD	1Y	3YCAGR	5YCAGR	10YCAGR	LaunchCAGR
ETF	+1.9%	+3.5%	+1.0%	—	—	—	—	—	+2.8%
Health average	6.4%	4.0%	21.1%	20.0%	23.8%	20.2%	3.9%	10.1%	11.2%
Difference	-4.6%	-0.4%	-20.1%	—	—	—	—	—	-8.4%

Holdings

Allocation as last published by the fund.

Credit quality

Share of the bonds by rating.

US government40.3%

Asset mix

Cash93.0%
Bonds8.0%

ETF details

Issuer: Graniteshares
Category: Equity · Health
Ticker: BIOY
Exchange: Nasdaq
Inception: 4 May 2026 (0.5 years)
Structure: Exchange Traded Fund
Expense ratio: 1.07% (category 0.88%)
Holdings turnover: 0% (category 68%)
Distribution yield: —
Beta, 3 years: 0.00
Total net assets: $1.5M

Prices and returns as of 12 Nov 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.

Other health ETFs

Other ETFs in the Health category.

Compare Option Income ETFs